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Vitamin D is not really a vitamin.1 Vitamin D (which includes both D2 and D3) behaves like a hormone and 
carries out essential biological functions through 
endocrine, paracrine, and intracrine mechanisms.2 
Vitamin D2 (ergocalciferol) is a synthetic product 
produced by irradiation of plant sterols, while 
vitamin D3 (cholecalciferol) is a prohormone made 
in the skin in response to the action of ultraviolet 
(UV) B irradiation on a cholesterol precursor, 
7-dehydrocholesterol.1,3 When the skin absorbs 
UVB radiation, the precursor is converted to 
previtamin D3, which undergoes a thermally 
induced transformation to vitamin D3
 [Figure 1].3
A small part of vitamin D3 comes from dietary 
intake, especially fatty fish (e.g. herring, mackerel, 
sardines, tuna, salmon), eggs, and fortified foods. 
4,5 Thus, the major source of vitamin D is sunlight 
exposure. However, variables such as time of day, 
season, latitude, clothing, skin pigmentation, and 
age affect the amount of vitamin D converted in the 
skin.3 




هذا املرض املتوّطن الّسّري مل يُعد خفّيا
موؤن�س م�سطفى ال�س�ستاوي
امللخ�ص: وّفر العلماء حديثًا جمموعة قوية من الرباهني التي قّدمت معلومات جديدة عن التاأثري الوقائي لفيتامني »د« على جمموعة 
وا�سعة من احلاالت املر�سية. وت�سري هذه االأدلة اإىل اأّن فيتامني »د« هو اأكرث بكثري من جمرد مادة غذائية الزمة ل�سّحة العظام بل هو 
هرمون اأ�سا�سي �رضوري لتنظيم عدد كبري من الوظائف الف�سيولوجية. اإن وجود تركيز كايف من 25 -هيدروك�سي فيتامني »د« يف م�سل 
الدم هو اأمر �رضوري لتح�سني �سّحة االإن�سان. ن�ستعر�س يف هذا املقال احلالة الراهنة للمعارف العلمية حول و�سع فيتامني »د« يف جميع 
اأنحاء العامل، ون�سري اإىل مقاالت ُن�رضت حديثا والتي تناق�س بع�سا من اجلوانب املهمة العامة لفيتامني »د«، مبا يف ذلك امل�سادر، الفوائد، 
واحلاجة اليومية لفيتامني »د« الغذائية ونق�س تناوله خ�سو�سا يف فرتة احلمل. وتوفر الدرا�سة اأدلة على اأن نق�س فيتامني »د« ميكن اأن 
يكون عبئا كبريا على ال�سحة العامة يف اأجزاء كثرية من العامل، ومعظمها ب�سبب احلرمان من التعر�س الأ�سعة ال�سم�س. كما نناق�س اأي�سا 
اجلدل الدائر حول الرتكيز االأمثل ملادة 25 -هيدروك�سي فيتامني »د« يف م�سل الدم، وا�ستطالع وجهات النظر املختلفة ب�ساأن الكمية 
املطلوبة من مكمالت فيتامني »د« لتحقيق هذا الرتكيز واحلفاظ عليه.
مفتاح الكلمات: نق�س فيتامني »د«، 52-هيدروك�سي فيتامني »د«، فيتامني »د2« )اإرجوكال�سيفرول(، فيتامني »د3« )كولكال�سيفرول(،اأ�سعة 
ال�سم�س، ُعمان.
abstract: Recently, scientists have generated a strong body of evidence providing new information about the 
preventive effect of vitamin D on a broad range of disorders. This evidence suggests that vitamin D is much more 
than a nutrient needed for bone health; it is an essential hormone required for regulation of a large number of 
physiological functions. Sufficient concentration of serum 25-hydroxyvitamin D is essential for optimising human 
health. This article reviews the present state-of-the-art knowledge about vitamin D’s status worldwide and refers 
to recent articles discussing some of the general background of vitamin D, including sources, benefits, deficiencies, 
and dietary requirements, especially in pregnancy. They offer evidence that vitamin D deficiency could be a major 
public health burden in many parts of the world, mostly because of sun deprivation. The article also discusses the 
debate about optimal concentration of circulating serum 25-hydroxyvitamin D, and explores different views on 
the amount of vitamin D supplementation required to achieve and maintain this concentration. 








kidney to 1,25-dihydroxyvitamin D (1,25(OH)2D), 
which circulates in the blood as a hormone 
to regulate mineral and skeletal homeostasis 
[Figure 1].3 In addition to the kidney’s endocrine 
production of circulating 1,25(OH)2D, vitamin D 
Vitamin D, whether absorbed through the 
skin or consumed, is metabolised in the liver by 
25-hydroxylase to 25-hydroxyvitamin D (25(OH)
D), a prehormone form.1,3 In its endocrine action, 
25(OH)D is converted by hydroxylation in the 
Figure 1: Production, metabolism and functions of vitamin D
Vitamin D Deficiency 
This clandestine endemic disease is veiled no more
142 | SQU Medical Journal, May 2012, Volume 12, Issue 2
an adequate intake of dairy products.19 
In Oman, according to the 2004 Ministry of 
Health survey, out of 298 non-pregnant women of 
child bearing age, 21.4% were found to be vitamin 
D deficient (<27.0 nmol/L).20 Almost half of the 
women included in the survey (47%) had serum 
25(OH)D concentrations below 37.5 nmol/L, while 
only 10% of them had concentrations above 75 
nmol/L.21 A more recent study tested serum 25(OH)
D concentrations in 41 apparently healthy Omani 
women of childbearing age. The study indicated 
that all women had serum 25(OH)D concentrations 
of <50 nmol/L.22 Another study examined serum 
25(OH)D concentrations in 103 healthy Omani 
pregnant women on their first antenatal visit to the 
hospital. The study revealed that 33% of cases had 
‘at risk’ concentrations (25(OH)D) <25 nmol/L), 
and that 65% had serum concentrations of 25(OH)
D between 25 and 50 nmol/L, and not one case 
was found in the optimal range (25(OH)D >75 
nmol/L).23 
Similarly, vitamin D deficiency was found to 
be highly prevalent in the United Arab Emirates 
(UAE). Studying the efficacy of daily and monthly 
supplementation with vitamin D2 in lactating and 
nulliparous Emirati women, the results revealed 
that most women had vitamin D deficiency 
(25(OH)D ≤ 50 nmol/L at study entry).24 Also, 
Dawodu et al. investigated the effect of sun 
exposure at recommended levels on the vitamin 
D status of eight healthy Arab women of child-
bearing age working in the Al Ain district of the 
UAE. Serum 25-hydroxyvitamin D concentrations 
were measured pre- and post-intervention. 
Although vitamin D concentrations remained sub-
optimal, median serum 25(OH)D concentrations 
were significantly higher post-intervention (23.0 
nmol/L) than pre-intervention (17.6 nmol/L).25 
A very recent study done by Anouti et al. in 2011 
investigated a random sample of 208 young Emirati 
university students in Abu Dhabi, 138 females and 
70 males. The mean serum 25(OH)D concentration 
for female students tested in April was 31.3 ± 12.3 
nmol/L, while in October, it was 20.9 ± 14.9 nmol/L. 
26 This difference was statistically significant, 
suggesting that seasonal variation plays an 
important role in vitamin D status. Female students 
scored significantly higher than males on the sun 
avoidance inventory (SAI), indicating that females 
tend to avoid sun exposure to a greater extent than 
also acts through a paracrine-intracrine pathway. In 
this system, 25(OH)D is converted to 1,25(OH)2D 
intracellularly by 25(OH)D 1-a-hydroxylases in a 
variety of end-organ tissues such as the prostate 
gland, breasts, colon, lungs, and keratinocytes 
[Figure 1].6 The conversion of 25(OH)D to 
1,25(OH)2D in these tissues appears not to be 
controlled by calcium, but rather to be directly 
linked to the substrate availability of 25(OH)D. That 
is a complex endocrine reaction which begins in the 
largest organ of the body, the skin.2 
In contrast to 1,25(OH)2D, which has a short 
half-life of ~4–15 hours, the serum concentration of 
25(OH)D has a fairly long circulating half-life of ~15 
days,7 and is considered the best indicator of vitamin 
D status that can be measured.8 Serum 25(OH)D 
reflects vitamin D produced cutaneously and also 
that obtained from food and supplements.7–9 
Vitamin D Status around 
the World
Vitamin D status has been studied on all continents 
and in most countries throughout the world. In 
total, approximately 5,060 epidemiological studies 
have been done according to a PubMed search 
conducted in February 2012. These studies revealed 
that vitamin D deficiency was prevalent across all 
age-groups, geographic regions, and seasons.10–12 
Despite ample sunshine, vitamin D deficiency 
is very common in the Middle East (15°–36°N) 
and African (35°S–37°N) countries.13,14 The first 
study to reveal low vitamin D concentrations in 
people of the Middle East region was conducted 
by Woodhouse and Norton in 1982 among ethnic 
Saudi Arabians.15 Their results were confirmed 
in 1983, when Sedrani et al. recorded a mean 
25(OH)D concentration ranging between 10–30 
nmol/L (2.496 nmol/L being equivalent to 1 ng/
ml) among Saudi university students and the 
elderly.16,17 A more recent study that was conducted 
in the Eastern Province of Saudi Arabia revealed 
vitamin D deficiency (25(OH)D of ≤50 nmol/L) 
among 28–37% of 200 randomly selected healthy 
men.18 Another study, also conducted in the eastern 
regions of Saudi Arabia, showed low serum 25(OH)
D concentrations among both males and females 
(25.25 nmol/L and 24.75 nmol/L, respectively) 
despite the fact that >65% of participants had 
adequate exposure to sunlight and >90% reported 
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elsewhere, vitamin D deficiency was found to be 
common among pregnant women.35 
Most clinicians believe that vitamin D 
deficiency has been essentially eliminated in the 
USA, but recent data indicate that the diagnosis 
exists in epidemic proportions.36 Data from the 
National Health and Nutrition Examination 
Survey (NHANES) showed that the number of 
persons with 25(OH)D concentrations below 75 
nmol/L nearly doubled between the 1994 and 2004 
surveys, each of which extended for several years 
each.37 Data from the NHANES III 2004 survey 
showed that 65–75% of the population had 25(OH)
D concentrations of  <50 nmol/L.12 Less than 3% 
of African-American mothers were vitamin D 
sufficient, and the mean cord blood concentrations 
of 25(OH)D in their infants was very low (25 ± 15 
nmol/L).37,38 More recent research from the USA 
also studied vitamin D concentrations in different 
ethnic groups, and included 154 African-American, 
194 Hispanic, and 146 Caucasian women at <14 
weeks of gestation. In logistic regression models, 
race was the most important risk factor for vitamin 
D deficiency or insufficiency. African-American 
women and Hispanic women were more likely to 
have vitamin D insufficiency and deficiency than 
Caucasian women.39 Also, Bodnar et al. conducted 
a study to assess, by race and season, the vitamin 
D status of pregnant women and their neonates 
residing in Pittsburgh. The serum 25(OH)D of 200 
white and 200 black pregnant women was measured 
throughout gestation (4–21 weeks), previous to 
delivery, and in the cord blood of their neonates. 
The results suggested that black and white pregnant 
women and their neonates residing in the northern 
USA were at high risk of vitamin D insufficiency.40 
Thus, it seems that the world is facing today 
what is, in fact, a new endemic disease that was, 
until recently, totally veiled. The actual percentage 
of vitamin-D-deficient people seems to be far 
greater than reported, so identifying the reasons for 
the dramatic increase in vitamin D insufficiency is 
not an easy task. 
Vitamin D Deficiency - 
Causes and Questions
Declines in 25(OH)D concentrations are usually the 
result of dietary inadequacy, impaired absorption 
and use, increased requirements, or increased 
males, a possible explanation of the lower vitamin 
D status.26 
In Qatar, the mean overall vitamin D 
concentration among health care professionals 
working at Hamad Medical Corporation in 
Doha, was found to be 29.3 nmol/L. Vitamin D 
concentration was lower in females (25.8 nmol/L) 
than in males (34.3 nmol/L). A  total of 97% of all 
participants had a mean concentration <75 nmol/L, 
while 87% had a mean concentration of <50 
nmol/L.27 In another study, vitamin D deficiency 
was prevalent (68.8%) among young Qatari children 
below 16 years of age, mostly in the age group 11–
16 years (61.6%). Girls were affected more than boys 
(51.4% versus 48.6%).28
Even in north African countries there is a high 
prevalence of low vitamin D status; 25(OH)D is 
in the rachitic range. Veiled women, or women 
wearing purdahs (cloth that covers the whole of 
the body), have a lower vitamin D status than their 
peers within the same country.29 Studies in Turkey 
and Jordan showed also a strong relationship with 
clothing.30,31 Serum 25(OH)D levels were highest in 
women who wore Western clothing, decreasing in 
traditional women wearing a hijab (veil that covers 
the whole head except the face), and the lowest 
levels were measured in completely veiled women 
who wore a niqab (additional veil covering the 
whole face, or all of it except the eyes). Men in these 
countries have higher concentrations than women. 
In Iran, a population study that included 1,210 men 
and women between 20 and 69 years old, showed 
that the mean serum 25(OH)D was 20.6 nmol/L.32 
In India, among 20 pregnant women in delivery at 
Sant Parmanand Hospital in Delhi, more than 75% 
were deficient in 25(OH)D (<50 nmol/L).33 
Serum 25(OH)D concentrations are not only 
suboptimal in eastern or southern countries 
or specific risk groups, but also in adults in 
many Western countries.4 For instance, in the 
Netherlands, a study that assessed the prevalence 
of vitamin D deficiency in 358 pregnant women of 
several ethnic backgrounds living in The Hague, 
recorded that mean serum 25(OH)D concentrations 
in Turkish women were 15.2 ± 12.1 nmol/L; in 
Moroccan women 20.1 ± 13.5 nmol/L, and in 
other non-Western women 26.3 ± 25.9 nmol/L. 
These concentrations were significantly (P ≤0.001) 
lower than those in the Western women living in 
that country (52.7 ± 21.6 nmol/L).34 In the UK and 
Vitamin D Deficiency 
This clandestine endemic disease is veiled no more
144 | SQU Medical Journal, May 2012, Volume 12, Issue 2
to maintain blood calcium concentrations.1 
Moreover, sufficient concentrations of vitamin 
D may be important in reducing the occurrence 
of autoimmune diseases, such as multiple 
sclerosis, rheumatoid arthritis, diabetes, and some 
cancers.46–48,10 Adequate vitamin D may also allow 
for a normal innate immune response to pathogens, 
improve cardiovascular function and mortality and 
increase insulin responsiveness1,49,50 
A recent work by Grant aimed to estimate the 
reduction in mortality rates for six geopolitical 
regions of the world. It was based on an 
interpretation of the journal literature relating to 
the effects of solar UVB and vitamin D in reducing 
the risk of vitamin D-sensitive diseases. Six major 
diseases that account for more than half of global 
mortality rates (i.e. cardiovascular disease (CVD), 
cancer, respiratory infections, respiratory diseases, 
tuberculosis and diabetes mellitus) were studied 
in addition to vitamin D-sensitive diseases and 
conditions that account for 2–3% of global mortality 
rates such as Alzheimer’s disease, falls, meningitis, 
Parkinson’s disease, maternal sepsis, maternal 
hypertension (pre-eclampsia) and multiple sclerosis. 
The study showed that increasing serum 25(OH)
D concentrations from 54 to 110  nmol/L would 
reduce the vitamin D-sensitive disease mortality 
rates by an estimated 20%. The reduction in all-
cause mortality rates ranged from 7.6% for African 
females to 17.3% for European females. Reductions 
for males were on average 0.6% lower than for 
females. The estimated increase in life expectancy 
was 2 years for all six regions.51
Why should we be 
concerned about Vitamin 
D Deficiency during 
Pregnancy? 
Generally, there are many important health benefits 
from vitamin D for both mother and fetus. However, 
new clinical research results over the past decade 
indicate that appropriate intakes of vitamin D may 
provide greater health benefits than previously 
thought, benefits that include not only improved 
bone health, but other effects as well.2,52,53 Recent 
data suggest that 1,25(OH)2D aids implantation 
and maintains normal pregnancy. It also supports 
fetal growth through delivery of calcium, controls 
secretion of multiple placental hormones, and limits 
excretion.9 No doubt, the major cause of vitamin D 
deficiency is inadequate exposure to sunlight.41–44 
The upward trend in body mass index is also 
accused of causing vitamin D deficiency, and obesity 
is now added as a major contributory factor to the 
increasing prevalence of vitamin D insufficiency.3 
Genetic predisposition may also have an effect on 
vitamin D blood concentrations and it has to be 
accounted for in the design of preventive measures 
against vitamin D deficiency.1,45
A century since the discovery of its dual origin, 
many questions have been raised and remain 
unanswered about vitamin D’s concentrations in 
human beings. For example, why is vitamin D so 
important? Why should we be concerned about 
vitamin D deficiency during pregnancy? What 
concentrations of the vitamin are optimal in adults 
and children? Do these optimal concentrations 
vary for the prevention of various disorders or in 
differing human populations? What amount of 
supplementation or sunlight exposure is needed to 
achieve and maintain these concentrations? And 
how much vitamin D can we really take safely? 
Luckily, in the last few years, numerous clinical 
studies, including crucial randomised controlled 
trials (RCTs) of vitamin D supplementation 
were conducted in the search for answers to the 
above mentioned questions and more. Successful 
completion of experimental trials was essential to 
obtain valuable information on the effect of vitamin 
D in preventing a wide range of disorders, and also 
for establishing the efficacy and safety of vitamin D 
supplementation.
Why is Vitamin D so 
Important? 
Vitamin D is much more than a nutrient needed for 
bone health; it is an essential hormone required for 
the regulation of a large number of physiological 
functions. Its receptors were found to be present 
in nearly every tissue and cell in the body. That is 
why sufficient concentrations of serum 25(OH)D 
are essential for optimal functioning of these tissues 
and cells.3 
The major function of vitamin D compounds is 
to enhance the active absorption of ingested calcium 
(and phosphate). This assists in building bone at 
younger ages and ensures that, despite obligatory 
urinary losses, bone does not need to be desorbed 
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literature. The panel reached substantial agreement 
about the need for vitamin D supplementation in 
adult patients with, or at risk for fractures, falls, 
cardiovascular or autoimmune diseases, and cancer. 
A target range of at least 75 to 100 nmol/L was 
recommended.53 
However, one study of a convenience sample 
of 93 healthy young adults recruited from the 
University of Hawaii and a Honolulu skateboard 
shop questioned the frequently suggested serum 
25(OH)D sufficiency cutoff of 75 nmol/L. The 
investigators recruited these prototypic “surfer 
dudes” (mean age: 24 years; mean body mass index 
[BMI], in kg/m2: 23.6). On the basis of a self-reported 
minimum outdoor sun exposure of 15 hours (mean: 
29 hours) per week during the preceding 3 months; 
40% reported never using sunscreen, and the group 
overall reported an average of 22.4 hours per week 
of unprotected sun exposure. All were clinically 
tanned. Nevertheless, the group’s mean 25(OH)
D concentration was 79 nmol/L, and 51% had a 
concentration below the suggested 75 nmol/L cutoff 
for sufficiency. The study group was multiracial, but 
even among the 37 white subjects, the mean value 
was only 92.8 nmol/L and the highest value was 155 
nmol/L.63 
On the other hand, Luxwolda et al. measured 
the sum of serum 25-hydroxyvitamin D2 and D3 
(25(OH)D) concentrations of thirty-five pastoral 
Maasai (mean age: 34 ± 10 years, 43% male) and 
twenty-five Hadzabe hunter-gatherers (mean age: 
35 ± 12 years, 84% male) living in Tanzania. They had 
skin type VI, wore a moderate degree of clothing, 
spent the majority of the day outdoors, but avoided 
direct exposure to sunlight when possible. The mean 
serum 25(OH)D concentrations of Maasai and 
Hadzabe were 119 (range 58–167) and 109 (range 
71–171) nmol/L, respectively. These concentrations 
were not related to age, sex, or BMI.64 These recent 
data suggest that a public health goal of ≥75 nmol/L, 
or even ≥100 nmol/L, for the entire population can 
be achieved by sun exposure. 
How much Vitamin D is 
required to Optimise Bone 
and Global Health? 
In 2011, the IOM released revised recommendations 
for the daily intake of vitamin D based on the body’s 
need for skeletal health.9  The recommended dietary 
the production of proinflammatory cytokines.35,54 
Maternal nutritional vitamin D status has a good 
effect on childhood bone mineral accrual and is 
important also for fetal “imprinting” that may affect 
neurodevelopment, immune function, and chronic 
disease susceptibility later in life, as well as soon 
after birth.55,56 
Also, maternal vitamin D insufficiency during 
pregnancy is significantly associated with offspring 
language impairment. Maternal vitamin D 
supplementation during pregnancy may reduce the 
risk of developmental language difficulties among 
children.57 Meanwhile, substandard vitamin D 
intake during pregnancy may lead to decreased birth 
weight.58 Moreover, maternal vitamin D deficiency 
in early pregnancy may be an independent risk 
factor for preeclampsia59 and may be associated 
with increased odds of primary caesarean section.60 
Merewood et al. found that 28% of women with 
serum 25(OH)D concentrations less than or equal 
to 37.5 nmol/L had a caesarean section, compared 
with only 14% of women with higher 25(OH)D 
concentrations (≥37.5 nmol/L).60 
What is the “Normal” 
Circulating 25(OH)D 
Concentration in Human 
Beings? 
Vitamin D deficiency has been historically defined 
and recently recommended by the Institute of 
Medicine (IOM), USA,  as a 25(OH)D concentration 
of less than 50 nmol/L. Vitamin D insufficiency has 
been defined as a 25(OH)D concentration of 50–
75 nmol/L.61 Vitamin D deficiency can be further 
classified as mild (25–50 nmol/L), moderate (12.5–
25.0 nmol/L), and severe (<12.5 nmol/L).5 However, 
the preponderance of evidence points to optimal 
serum 25(OH)D concentrations of at least 80 nmol/L 
to maximise vitamin D’s effect on calcium, bone, and 
muscle metabolism.3,50,62 Based on a quick review of 
the literature for vitamin D during pregnancy, as 
well as a more detailed review for other diseases, 
Grant found that serum 25(OH)D concentrations 
above 75–100 nmol/L are required for good 
pregnancy outcomes, fetal health, and optimal 
health in general.35 Similarly, an international expert 
panel formulated recommendations on vitamin D 
for clinical practice, taking into consideration the 
best recent evidence available based on published 
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received 400, 2,000 or 4,000 IU vitamin D3 per day 
until delivery. The relative risk (RR) for achieving 
≥80 nmol/L within one month of delivery was 
significantly different between 2,000 and 400 IU. 
Circulating 25(OH)D had a direct influence on 
circulating 1,25(OH)2 D concentrations throughout 
pregnancy with maximal production of 1,25(OH)2 
D in all strata in the 4,000 IU group. There were no 
differences between groups on any safety measure. 
Not a single adverse event was attributed to 
vitamin D supplementation or circulating 25(OH)
D concentrations.69 Another study by Hollis was 
conducted in Columbia, South Carolina, USA. 
The study included diverse groups of women who 
were randomised to 2,000 or 4,000 IU vitamin D3/
day irrespective of baseline 25(OH)D at <16 weeks’ 
gestation. The aim was to confirm the NIH/NICHD 
study findings and to prove that no adverse events 
are associated with vitamin D supplementation.70 
Both of these studies proved that vitamin D 
supplementation with 4,000 IU vitamin D/day for 
pregnant women was safe and effective in achieving 
vitamin D sufficiency in a racially diverse group. In 
both studies, higher maternal circulating 25(OH)D 
was associated with a lower risk of co-morbidities 
of pregnancy. 
What are the Possible 
Effects on Health of High 
Concentrations of  
Vitamin D? 
According to Heaney, an intake of 1,000 IU vitamin 
D/day results in an increase of approximately 
25 nmol/L in 25(OH)D, although individual 
responses vary.71 Accordingly, most international 
authorities consider a vitamin D intake of 2,000 IU/
day as absolutely safe, although literature review 
revealed that even doses of up to 10,000 IU/day 
supplemented over several months did not lead to 
any adverse events.52 
In 2011, the IOM re-evaluated the potential for 
high intakes of vitamin D to produce adverse effects 
and set a safe tolerable upper intake level (UL) for 
vitamin D of 4,000 IU/day for ages 9 and older 
and lower for infants (0–6 months: 1,000 IU/day; 
6–12 months: 1500 IU/day) and younger children 
(1–3 years: 2,500 IU/day; 4–8 years: 3,000 IU/day).9 
According to Ross et al., the starting point for the 
announced UL for vitamin D was 10,000 IU/day. 
allowances (RDAs) for vitamin D are 600 IU/d for 
ages 1–70 years and 800 IU/d for ages 71 years and 
older, corresponding to a serum 25-hydroxyvitamin 
D concentration of at least 50 nmol/L. RDAs for 
vitamin D were based on conditions of minimal 
sun exposure due to wide variability in vitamin 
D synthesis from UV light and the risks of skin 
cancer.65 
The recommendations of the American 
Academy of Pediatrics (AAP) are 400 IU/day of 
vitamin D for exclusively and partially breastfed 
infants shortly after birth, to be continued until they 
are weaned and consume ≥1,000 mL/day of vitamin 
D-fortified formula or whole milk. Similarly, all 
non-breastfed infants ingesting <1,000 ml/day of 
vitamin D-fortified formula or milk should receive a 
vitamin D supplement of 400 IU/day. The AAP also 
recommends that older children and adolescents 
who do not obtain 400 IU/day through vitamin 
D-fortified milk and foods should take a 400 IU 
vitamin D supplement daily.66 However, this latter 
recommendation, issued in November 2008, is 
less than the Food and Nutrition Board’s vitamin 
D RDA of 600 IU/day for children and adolescents 
that was issued in November 2010.67 
All these recommendations have stimulated 
considerable debate. Many scientists thought that 
to increase nutritional vitamin D to meaningful 
concentrations, dietary intakes of ≥2,000 IU/day 
may be required. In order to calculate the needs 
of a human body, one should know that sunlight 
exposure sufficient to result in a mild sunburn for 
a Caucasian adult in a bathing suit raises the serum 
25(OH)D to a concentration comparable to that 
of a person taking 10,000 to 20,000 IU of vitamin 
D2 orally; which could be the daily requirement 
for human beings. 68 Thus, raising the blood 
concentration of 25(OH)D consistently above 75 
nmol/L may require at least 1,000–2,000 IU/day of 
supplemental vitamin D.53 Higher concentrations 
of 2,000 IU/day for children 0–1 years, 4,000 IU/
day for children 1–18 years, and 10,000 IU/day 
for children and adults 19 years and older may be 
needed to correct vitamin D deficiency.50 
To end the debate, Bruce Hollis et al. have 
recently conducted a randomised controlled 
trial, the National Institutes of Health/National 
Institute of Child Health & Human Development 
(NIH/NICHD) study, in which women with a 
singleton pregnancy at 12–16 weeks’ gestation 
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of calculating UV exposure times and clearly 
indicates that it is impractical to generate a simple 
nationally uniform message that prescribes minutes 
of sun exposure to the general population, given 
the number of variables that need to be taken into 
consideration.79 In response to potential confusion 
over mixed messages about the risks and benefits of 
sun exposure, a collaboration of the Cancer Council 
Australia, the Australian and New Zealand Bone 
and Mineral Society, Osteoporosis Australia and the 
Australasian College of Dermatologists gathered 
Australian experts in Melbourne in December 
2006, to review the latest evidence on vitamin D 
and develop a position statement.80 Those experts 
suggested that people should continue to protect 
themselves from overexposure, especially during 
peak ultraviolet radiation periods (10 am to 3 pm). 
For most people, sun protection to prevent skin 
cancer is required when the UV index is moderate 
or above (i.e. UV index is 3 or higher). At such times, 
sensible sun protection behaviour is warranted 
and is unlikely to put people at risk of vitamin D 
deficiency. Most people probably achieve adequate 
vitamin D concentrations through the UVB 
exposure they receive during typical day-to-day 
outdoor activities. For example, fair skinned people 
can achieve adequate vitamin D concentrations 
(>50 nmol/L) in summer by exposing the face, 
arms and hands or the equivalent area of skin to a 
few minutes of sunlight on either side of the peak 
UV periods on most days of the week. In winter, 
when UV radiation concentrations are less intense, 
maintenance of vitamin D concentrations may 
require 2–3 hours of sunlight exposure to the face, 
arms and hands or equivalent area of skin over a 
week.80
Second, some groups in the community are at 
increased risk of vitamin D deficiency. They include 
naturally dark-skinned people, those who cover 
their skin for religious or cultural reasons, the 
elderly, infants of vitamin D deficient mothers, and 
people who are housebound or are in institutional 
care.80 Naturally dark-skinned people (Fitzpatrick 
skin type 5 and 6) are relatively protected from 
skin cancer by the pigment in their skin; they could 
therefore safely increase their sun exposure. Others 
on this list should discuss their vitamin D status 
with their medical practitioner as some might 
benefit from dietary supplementation with vitamin 
D.80
Given that toxicity is not the appropriate basis for 
a UL that is intended to reflect long-term chronic 
intake and to be used for public health purposes, 
this value was corrected for uncertainty based on 
chronic disease outcomes and all-cause mortality 
to 4,000 IU/day.65 However, Garland and colleagues 
pointed out that the supplemental dose, ensuring 
that 97.5% of the population study achieved a serum 
25(OH)D of at least 100 nmol/L, was 9,600 IU/day.72 
It should be mentioned here that sunbathing 
can produce vitamin D doses equivalent to an 
oral vitamin D intake of up to 20,000 IU/day and 
in healthy subjects who spent prolonged periods 
in a sunny environment, measured 25(OH)
D concentrations rarely exceed 250 nmol/L, 
suggesting that this level may be considered a 
safe upper limit for serum 25(OH)D levels.73–75 
Furthermore, a benefit-risk assessment of vitamin 
D supplementation conducted by Bischoff-Ferrari 
et al. reported that hypercalcaemia caused by excess 
vitamin D in generally healthy adults was observed 
only if daily intake was >100,000 IU or if the 25(OH)
D level exceeded 250 nmol/L.76 Accordingly, they 
pointed out that 250 nmol/L should be considered 
a safe limit, but not as an upper limit to target in 
clinical practice.53 Similarly, Hathcock et al., noting 
the absence of toxicity in clinical trials conducted in 
healthy adults that used vitamin D doses of ≥10,000 
IU, supported the confident selection of this value 
as the UL.52 
Conclusion 
Over the past two decades, scientists, clinicians 
and researchers have generated a strong body of 
evidence to address the problem of vitamin D 
deficiency and provide advice for correcting its 
status among all ages, genders and racial/ethnic 
groups. Many studies, some randomised and 
some not, have suggested that a population with a 
higher vitamin D intake would be healthier overall. 
Accordingly, the following can be recommended
First, vitamin D can be obtained from production 
by the skin after brief UV exposure. Exposure to 
bright midday sunlight, rich in UVB wavelengths, is a 
very efficient way to make vitamin D. Unfortunately, 
the action spectrum for vitamin D photosynthesis is 
essentially identical to the spectrum that damages 
DNA and causes skin cancer.77,78 The study done by 
Samanek et al. in 2006 illustrates the complexities 
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Both the USA and Canada mandate the fortification 
of infant formula with vitamin D: 40–100 IU/100 
kcal in the USA, and 40–80 IU/100 kcal in Canada.9 
Sixth, in supplements and fortified foods, vitamin 
D is available in two forms, D2 (ergocalciferol) and 
D3 (cholecalciferol), which differ chemically only 
in their side-chain structure. However, Vitamin D3 
is approximately 87% more potent in raising and 
maintaining serum 25(OH)D concentrations and 
produces 2- to 3-fold greater storage of vitamin 
D than does vitamin D2.
81 Accordingly, vitamin 
D3 should be the preferred treatment option 
when correcting vitamin D deficiency through 
supplementation using an intermittent regimen.82,83 
However, when given as daily doses, vitamin D2 and 
D3 seem to have similar effects on 25(OH)D levels.
84 
Seventh, the use of UVB irradiance may be 
useful in certain cases. Solar UVB radiation 
with a wavelength of 290–320 nanometers 
penetrates uncovered skin and converts cutaneous 
7-dehydrocholesterol to previtamin D3, which 
in turn becomes vitamin D3.
9 However, the most 
commonly used lamps do a poor job of simulating 
the UVB light intensity of natural sunlight. The only 
lamps that come close to the intensity of natural 
sunlight are “sunlamps”, which are sometimes used 
to treat psoriasis.85 The moderate use of commercial 
tanning beds that emit 2–6% UVB radiation is also 
effective.86,87 
Eighth, in practice, testing for 25(OH)
D is recommended after at least 3 months of 
supplementation (usually 6–12 months).50 Currently, 
25(OH)D measurement is reasonable in groups of 
people at high risk for vitamin D deficiency and in 
whom a prompt response to optimisation of vitamin 
D status is expected.61 However, serum 25(OH)
D assays are expensive, and the need for universal 
screening has not yet been proven.3
acknowledgment
I should particularly like to acknowledge the insights 
and expert guidance given to me by William B. 
Grant, Director of Sunlight, Nutrition, and Health 
Research Center (SUNARC), San Francisco, 
California, USA. Dr. Grant was consistently 
encouraging and supportive and I appreciate very 
much his efforts in critically reviewing my article 
and making numerous helpful suggestions.
Third, some people are at high risk of skin 
cancer. They include people who have had skin 
cancer, have received an organ transplant, or 
are highly sun sensitive. These people need to 
have more sun protection, and therefore should 
discuss their vitamin D requirements with their 
medical practitioner to determine whether 
dietary supplementation with vitamin D would be 
preferable to sun exposure.80 
Fourth, public education should be provided 
about the safety of vitamin D supplementation. 
Individuals with limited sun exposure need to 
include reliable sources of vitamin D in their diet 
or take a supplement to achieve recommended 
concentrations of intake. Needless to say, there is 
considerable variation in how individuals respond 
to vitamin D supplementation. The response to 
treatment varies with season, population, local 
experience and with the starting concentrations 
of 25(OH)D. Supplementation without baseline 
25(OH)D measurement is recommended for dark-
skinned or veiled subjects not exposed much to 
the sun; individuals with musculoskeletal health 
problems; cardiovascular disease; autoimmune 
diseases and cancer; those over 65 years of age, 
and institutionalised subjects. In these individuals, 
a dose of 800 IU/day (the standard dose of most 
RCTs) or its equivalent with an intermittent dosing 
regimen (i.e. 100,000 IU orally every 3 to 4 months) 
is recommended.53,72 All adults who are vitamin 
D deficient should be treated with 50,000 IU of 
vitamin D once a week for 8 weeks, or its equivalent 
of 6,000 IU/day of vitamin D, to achieve a blood 
concentration of 25(OH)D ≥ 75nmol/L, followed 
by maintenance therapy of 1,500–2,000 IU /day.61 
Similarly, Pietras et al. effectively treated vitamin 
D deficiency in most patients with 50,000 IU of 
ergocalciferol weekly for 8 weeks, then continued 
treatment with 50,000 IU of ergocalciferol every 
other week for up to 6 years to prevent recurrent 
vitamin D deficiency.17 
Fifth, compulsory fortification of some foods 
(such as milk, infant formula, margarine, and other 
food products) with vitamin D should be seriously 
considered. Fortified foods can provide sufficient 
amounts of vitamin D in the diet. They provide most 
of the vitamin D in the American diet, and almost all 
of the USA milk supply is voluntarily fortified with 
100 IU/cup. In Canada, milk is fortified by law with 
35–40 IU/100 mL, as is margarine at ≥530 IU/100 g. 
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